FDA rule allows it to destroy intercepted drugs; LSL adds cooler and storage space in Indianapolis;

> The FDA is finalizing a rule that will allow it to destroy drugs valued at less than $2,500 that have been denied access to the U.S. Report

> According to a new market report, the pharma packaging market will grow to $8.1 billion in 2021 from about $5 billion last year, a CAGR of 6.8%. Release

> Enrollment at the Biomanufacturing Education and Training Center at Worcester Polytechnic Institute in Worcester, MA, more than doubled in the fiscal year ended June 30, 2015 to 349, which included students from companies like AbbVie ($ABBV), AstraZeneca ($AZN), Biogen ($BIIB), Pfizer ($PFE) and Shire ($SHPG). Release

> Life Science Logistics (LSL) is opening a new 2,350-square-foot vault and a 2,700-square-foot expansion of its existing cooler (2-8°C) at the company's 394,000-square-foot Indianapolis facility. Release

Suggested Articles

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.